Johnson Investment Counsel’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $747K | Sell |
8,257
-147
| -2% | -$12.3K | 0.01% | 518 |
|
|
2026
Q1 | $673K | Hold |
8,404
| – | – | 0.01% | 515 |
|
|
2025
Q4 | $716K | Sell |
8,404
-425
| -5% | -$34.9K | 0.01% | 470 |
|
|
2025
Q3 | $687K | Sell |
8,829
-200
| -2% | -$15.6K | 0.01% | 503 |
|
|
2025
Q2 | $706K | Buy |
9,029
+734
| +9% | +$54.7K | 0.01% | 478 |
|
|
2025
Q1 | $601K | Sell |
8,295
-200
| -2% | -$14.3K | 0.01% | 493 |
|
|
2024
Q4 | $629K | Sell |
8,495
-616
| -7% | -$43.1K | 0.01% | 480 |
|
|
2024
Q3 | $601K | Buy |
9,111
+16
| +0.2% | +$1.16K | 0.01% | 483 |
|
|
2024
Q2 | $840K | Sell |
9,095
-75
| -0.8% | -$6.64K | 0.01% | 403 |
|
|
2024
Q1 | $876K | Buy |
9,170
+288
| +3% | +$24.2K | 0.01% | 398 |
|
|
2023
Q4 | $677K | Hold |
8,882
| – | – | 0.01% | 424 |
|
|
2023
Q3 | $615K | Sell |
8,882
-1,095
| -11% | -$88K | 0.01% | 423 |
|
|
2023
Q2 | $941K | Buy |
9,977
+1,345
| +16% | +$117K | 0.01% | 362 |
|
|
2023
Q1 | $714K | Sell |
8,632
-22
| -0.3% | -$1.73K | 0.01% | 398 |
|
|
2022
Q4 | $646K | Sell |
8,654
-250
| -3% | -$19.3K | 0.01% | 411 |
|
|
2022
Q3 | $736K | Buy |
8,904
+189
| +2% | +$18.2K | 0.01% | 375 |
|
|
2022
Q2 | $829K | Buy |
8,715
+61
| +0.7% | +$6.32K | 0.01% | 361 |
|
|
2022
Q1 | $1.02M | Sell |
8,654
-53
| -0.6% | -$5.95K | 0.01% | 346 |
|
|
2021
Q4 | $1.13M | Hold |
8,707
| – | – | 0.01% | 332 |
|
|
2021
Q3 | $986K | Buy |
8,707
+5
| +0.1% | +$571 | 0.01% | 347 |
|
|
2021
Q2 | $901K | Sell |
8,702
-187
| -2% | -$17.6K | 0.01% | 348 |
|
|
2021
Q1 | $743K | Sell |
8,889
-25
| -0.3% | -$2.11K | 0.01% | 364 |
|
|
2020
Q4 | $813K | Sell |
8,914
-167
| -2% | -$13.9K | 0.01% | 338 |
|
|
2020
Q3 | $725K | Hold |
9,081
| – | – | 0.01% | 334 |
|
|
2020
Q2 | $628K | Sell |
9,081
-453
| -5% | -$32.2K | 0.01% | 356 |
|
|
2020
Q1 | $599K | Sell |
9,534
-654
| -6% | -$47.2K | 0.01% | 332 |
|
|
2019
Q4 | $792K | Buy |
10,188
+45
| +0.4% | +$3.51K | 0.01% | 353 |
|
|
2019
Q3 | $744K | Buy |
10,143
+894
| +10% | +$62.8K | 0.01% | 353 |
|
|
2019
Q2 | $569K | Hold |
9,249
| – | – | 0.01% | 401 |
|
|
2019
Q1 | $589K | Buy |
9,249
+24
| +0.3% | +$1.37K | 0.01% | 386 |
|
|
2018
Q4 | $470K | Sell |
9,225
-660
| -7% | -$33.4K | 0.01% | 408 |
|
|
2018
Q3 | $573K | Buy |
9,885
+558
| +6% | +$27.3K | 0.01% | 412 |
|
|
2018
Q2 | $452K | Sell |
9,327
-894
| -9% | -$41.7K | 0.01% | 445 |
|
|
2018
Q1 | $475K | Sell |
10,221
-732
| -7% | -$31.8K | 0.01% | 430 |
|
|
2017
Q4 | $411K | Sell |
10,953
-7,845
| -42% | -$288K | 0.01% | 469 |
|
|
2017
Q3 | $684K | Buy |
18,798
+810
| +5% | +$30.9K | 0.02% | 339 |
|
|
2017
Q2 | $708K | Buy |
17,988
+537
| +3% | +$19.6K | 0.02% | 317 |
|
|
2017
Q1 | $547K | Sell |
17,451
-180
| -1% | -$5.64K | 0.02% | 376 |
|
|
2016
Q4 | $550K | Sell |
17,631
-2,349
| -12% | -$76.1K | 0.02% | 348 |
|
|
2016
Q3 | $802K | Sell |
19,980
-216
| -1% | -$8.13K | 0.03% | 259 |
|
|
2016
Q2 | $671K | Hold |
20,196
| – | – | 0.02% | 281 |
|
|
2016
Q1 | $593K | Buy |
20,196
+516
| +3% | +$14.2K | 0.02% | 292 |
|
|
2015
Q4 | $518K | Sell |
19,680
-1,920
| -9% | -$49.9K | 0.02% | 318 |
|
|
2015
Q3 | $511K | Hold |
21,600
| – | – | 0.02% | 317 |
|
|
2015
Q2 | $512K | Hold |
21,600
| – | – | 0.02% | 316 |
|
|
2015
Q1 | $512K | Sell |
21,600
-102
| -0.5% | -$2.29K | 0.02% | 317 |
|
|
2014
Q4 | $460K | Hold |
21,702
| – | – | 0.02% | 337 |
|
|
2014
Q3 | $369K | Buy |
+21,702
| New | +$343K | 0.01% | 391 |
|
Other funds holding EW
Johnson Investment Counsel's EW Position: Q2 2026 in Review
Johnson Investment Counsel reduced its Edwards Lifesciences (EW) stake by 1.7% in Q2 2026, selling an estimated $12.3K and leaving 8,257 shares worth $747K. The position accounts for 0.01% of the portfolio, ranked #518.
Johnson Investment Counsel first reported a position in EW in Q3 2014 and has held it in 48 quarters since. The position peaked at $1.13M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Johnson Investment Counsel held 8,257 shares of Edwards Lifesciences worth $747K as of Q2 2026.
- Johnson Investment Counsel sold 147 Edwards Lifesciences shares in Q2 2026, an estimated $12.3K.
- Edwards Lifesciences made up 0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #518 holding.
- Johnson Investment Counsel first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 48 quarters since.
- Johnson Investment Counsel's Edwards Lifesciences position peaked at $1.13M in Q4 2021.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.